Medications
Resources
Basic InformationMore InformationLatest News
Health Tip: Packing Prescriptions for TravelDrug Errors Peak in July When New Docs StartFDA Warns Consumers Against Swallowing Topical BenadrylStudy Shows Some Anti-Seizure Meds Raise Suicide RiskU.S. Oftalmi Recalls Camolyn Eye Drops, Fisiolin Nasal DropsPrescriptions Translated to Spanish Could Be Hazardous to HealthTougher-to-Abuse Form of OxyContin ApprovedVaccines-By-Patch Good News for Needle-PhobicRifaximin Maintains Remission in Patients With Liver DiseaseMenstrual Cramps May Be Helped by New DrugNew Inhaled Insulin Shows Promise for DiabetesPlavix Can Help Cut Death Risk in Certain Heart PatientsFDA Asks Docs to Suspend Using Glaxo Rotavirus VaccineFDA Says High-Dose Simvastatin Ups Myopathy RiskHigh-Dose Zocor Boosts Muscle Injury Risk: FDAAvandia Researchers' Financial Ties QuestionedCarbaglu Approved for Rare Genetic DisorderACC: New Dual-Acting Drug Lowers Blood PressureNewer Blood Thinner Beats Plavix for Bypass PatientsArthritis Drug May Fight Diabetes, Too2 Drugs Fail to Prevent Diabetes in the OverweightFDA Adds Boxed Warning to Clopidogrel LabelThiazolidinediones Not Linked to Diabetic Macular EdemaYoung Kids to Benefit From Broader Pneumococcal VaccineBleeding Alert Sounded for Stroke DrugsHeartburn Drug Kapidex Renamed to DexilantLink Between Diabetes and Neuroleptic Drugs OutlinedResistance Likely to Develop With New Hepatitis C DrugsLasofoxifene Examined in Postmenopausal WomenSuccessor to Combination Pneumococcal Vaccine ApprovedMenveo Vaccine Approved for Bacterial MeningitisFDA: No Decision on Whether to Pull Diabetes Drug Avandia Off the MarketRituxan Approved for Chronic Lymphocytic LeukemiaNew Technology Could Widen Reach of VaccinesFDA Issues Warning on Key Asthma DrugsFDA Issues Maalox Total Relief WarningIbuprofen May Help Stave Off Parkinson'sFDA Tightens Controls on Anemia DrugsAdded Drug Aids MS Treatment'Fishy Smell' May Keep Patients From Diabetes DrugBotox May Prevent Some MigrainesAnother Study Refutes Vaccination-Autism LinkCrestor Approval ExpandedParoxetine May Compromise the Efficacy of TamoxifenNeedle Length May Affect Vaccination Results in ObeseDrug May Ease Cognitive Effects of Huntington'sGlaucoma Drugs May Play Role in Longer LifeH1N1 Vaccination Still Highly RecommendedThe Lancet Retracts Study Linking MMR Vaccine, AutismXiaflex Approved for Rare Hand Condition
Questions and AnswersLinksBook Reviews
Related Topics

Anxiety Disorders
Depression: Major Depression & Unipolar Varieties
Medical Disorders
Mental Disorders
Mental Health Professions

The 'Pill' Offers Benefits Beyond Birth Control

HealthDay News
by -- Robert Preidt
Updated: Dec 22nd 2009

new article illustration

TUESDAY, Dec. 22 (HealthDay News) -- Along with preventing pregnancy, hormonal contraceptives also treat menstruation-related disorders such as severe menstrual pain and heavy menstrual bleeding, according to a new Practice Bulletin issued by the American College of Obstetricians and Gynecologists.

The bulletin also said that combined contraceptives containing both estrogen and progesterone reduce the risk of endometrial, ovarian and colorectal cancer. Other potential benefits include prevention of menstrual migraines, treatment of pelvic pain caused by endometriosis and treatment of bleeding because of uterine fibroids.

"We've known for many years that hormonal contraceptives have health advantages beyond preventing pregnancy," Dr. Robert L. Reid, who led the development of the bulletin, said in a news release from the organization. "These recommendations examine the scientific data supporting the non-contraceptive uses of hormonal contraceptives to treat specific conditions."

"Combined oral contraceptives are effective in normalizing irregular periods, reducing symptoms of premenstrual dysphoric disorder, improving acne and allowing women to avoid having their period at inconvenient times, such as during a business trip, vacation or honeymoon," Reid added. "Although there is little data on the newer forms of hormonal contraception in terms of their off-label benefits, experts suggest that they may be as effective as the more studied ones in treating the same conditions."

The bulletin is published in the January issue of Obstetrics & Gynecology.

More information

The U.S. National Institute of Child Health and Human Development has more about menstrual irregularities.




To Access Services
Call (815) 224-1610
24 hours a day
7 days a week

info@ncbhs.org

Outpatient Center Locations in Illinois:

  • LaSalle
  • Ottawa
  • Streator
  • Princeton
  • Canton
  • Macomb

powered by centersite dot net